💊 Medicine AT September 22, 2026

Yuflyma 40 mg Injektionslösung in einer Fertigspritze 40 mg (Injektionslösung)

📷 Wikipedia: Adalimumab · Source

ATC: L04AB04
Reason: Erhöhter Mehrbedarf
Marketing authorisation holder: Celltrion Healthcare Hungary Ltd., Vaci Ut 1-3 Westend Office Building B Torony -, 1062 Budapest VI, Ungarn
Affected packs: 2 Stück Schachtel, Fertigspritze [eingeschränkt verfügbar, since 2026-09-22, resupply 2027-03-31]

⚠️

Shortage ongoing

ADALIMUMAB is currently in short supply in AT.

📈 Timeline

1 days active so far

September 24, 2026 September 24, 2026

Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

ADALIMUMAB

Agency-published detail

ATC: L04AB04 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Celltrion Healthcare Hungary Ltd., Vaci Ut 1-3 Westend Office Building B Torony -, 1062 Budapest VI, Ungarn · Affected packs: 2 Stück Schachtel, Fertigspritze [eingeschränkt verfügbar, since 2026-09-22, resupply 2027-03-31]

First published

September 22, 2026

Last refreshed by us

16 hours ago

Severity (as classified)

Medium

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 24, 2026

Agency-reported start

September 22, 2026

Days active

Related alerts

Medium AT 2 days ago

Yuflyma 40 mg Injektionslösung im Fertigpen 40 mg (Injektionslösung)

Medium AT 2 days ago

Yuflyma 80 mg Injektionslösung im Fertigpen 80 mg (Injektionslösung im Fertigpen)

Medium AT 3 weeks ago

Hukyndra 80 mg Injektionslösung im Fertigpen 80 mg (Injektionslösung im Fertigpen)

Hukyndra 80 mg injection solution in pre-filled pen 80 mg (injection solution in pre-filled pen) is affected.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Yuflyma 40 mg Injektionslösung in einer Fertigspritze 40 mg (Injektionslösung). ATC: L04AB04 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Celltrion Healthcare Hungary Ltd., Vaci Ut 1-3 Westend Office Building B Torony -, 1062 Budapest VI, Ungarn · Affected packs: 2 Stück Schachtel, Fertigspritze [eingeschränkt verfügbar, since 2026-09-22,...

▸ When was this alert issued?

This alert was issued on September 22, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.